Status:
COMPLETED
Heart Failure Patients Registry
Lead Sponsor:
AstraZeneca
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
This study is a multicenter non-interventional observational prospective registry. This non-interventional study (NIS) does not imply any intervention into a routine clinical practice, including choic...
Eligibility Criteria
Inclusion
- Age ≥ 18 years at the time of inclusion;
- Signed and dated written informed consent in accordance with ICH GCP and local law prior to inclusion in the study;
- Documented diagnosis of HF (according to Clinical Guidelines "Chronic Heart Failure", 2020, approved by MoH of RF) with typical symptoms/signs of HF consistent with I-IV functional classes of HF according to NYHA classification.
Exclusion
- The absence of signed ICF;
- The participation in any randomised controlled trial within 3 months before the inclusion in this study or during the participation in this study.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2024
Estimated Enrollment :
19990 Patients enrolled
Trial Details
Trial ID
NCT04709263
Start Date
December 21 2020
End Date
March 28 2024
Last Update
May 15 2025
Active Locations (65)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Akhtubinsk, Astrakhan Oblast, Russia
2
Research Site
Stary Oskol, Belgorod Oblast, Russia
3
Research Site
Gurievsk, Kaliningrad Oblast, Russia
4
Research Site
Rodniki Settlement, Kaliningrad Oblast, Russia